Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
138.1 USD | -2.08% | -1.86% | +20.45% |
12:52pm | BNP Paribas Exane Adjusts Price Target on Xylem to $168 From $160, Keeps Outperform Rating | MT |
31/05 | Goldman Sachs Adjusts Price Target on Xylem to $159 From $155 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.45% | 34.19B | |
+16.34% | 88.8B | |
+10.30% | 68.32B | |
+15.17% | 37.54B | |
+3.35% | 27.45B | |
+6.92% | 26.25B | |
-1.45% | 26.21B | |
+16.79% | 25.26B | |
+3.06% | 22.44B | |
+19.41% | 19.04B |
- Stock Market
- Equities
- XYL Stock
- News Xylem Inc.
- RBC Boosts Price Target on Xylem to $133 From $126, Maintains Outperform Rating